{"id":"https://openalex.org/W2028507366","doi":"https://doi.org/10.1159/000086739","title":"Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis","display_name":"Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-18","ids":{"openalex":"https://openalex.org/W2028507366","doi":"https://doi.org/10.1159/000086739","mag":"2028507366","pmid":"https://pubmed.ncbi.nlm.nih.gov/16088174"},"language":"en","primary_location":{"id":"doi:10.1159/000086739","doi":"https://doi.org/10.1159/000086739","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000086739","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2028507366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052196009","display_name":"Thomas Hultsch","orcid":"https://orcid.org/0009-0001-0272-9810","observed_orcids":["https://orcid.org/0009-0001-0272-9810"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Hultsch","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ 0793-1080, USA. thomas.hultsch@novartis.com","Novartis Pharmaceuticals Corporation, East Hanover, N.J., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ 0793-1080, USA. thomas.hultsch@novartis.com","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, N.J., USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016449107","display_name":"Alexander Kapp","orcid":"https://orcid.org/0000-0002-1748-6276","observed_orcids":["https://orcid.org/0000-0002-1748-6276"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Kapp","raw_affiliation_strings":["Division of Allergy and Immunology, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pa., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Immunology, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pa., USA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047011247","display_name":"Jonathan M. Spergel","orcid":"https://orcid.org/0000-0002-4658-5353","observed_orcids":["https://orcid.org/0000-0002-4658-5353"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan Spergel","raw_affiliation_strings":["Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":23.9897,"has_fulltext":false,"cited_by_count":150,"citation_normalized_percentile":{"value":0.99866012,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"211","issue":"2","first_page":"174","last_page":"187"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/topical-calcineurin-inhibitors","display_name":"topical calcineurin inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pimecrolimus","display_name":"pimecrolimus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":1.0},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.9380000233650208},{"id":"https://openalex.org/keywords/langerhans-cells","display_name":"Langerhans cells","score":0.878000020980835},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/th1-th2-balance","display_name":"Th1/Th2 balance","score":0.9340000152587891},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.890999972820282},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6940000057220459},{"id":"https://openalex.org/keywords/systemic-immunosuppression","display_name":"systemic immunosuppression","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2776028589","wikidata":"https://www.wikidata.org/wiki/Q417489","display_name":"Pimecrolimus","level":4,"score":0.9725638031959534},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.9495248794555664},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.9335287809371948},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.8123794198036194},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7661480903625488},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.6601576209068298},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5387706756591797},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5296741724014282},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45139357447624207},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.45047295093536377},{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.4303547143936157},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.356983482837677},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.25271204113960266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14027541875839233}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065095","descriptor_name":"Calcineurin Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000086739","doi":"https://doi.org/10.1159/000086739","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000086739","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},{"id":"pmid:16088174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16088174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology (Basel, Switzerland)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":87,"referenced_works":["https://openalex.org/W7493770","https://openalex.org/W25250444","https://openalex.org/W71303928","https://openalex.org/W91033764","https://openalex.org/W159000166","https://openalex.org/W1534735809","https://openalex.org/W1905533873","https://openalex.org/W1925602349","https://openalex.org/W1963665366","https://openalex.org/W1965831364","https://openalex.org/W1969666218","https://openalex.org/W1970993308","https://openalex.org/W1973105799","https://openalex.org/W1978897182","https://openalex.org/W1982056078","https://openalex.org/W1984366394","https://openalex.org/W1986044945","https://openalex.org/W1986100211","https://openalex.org/W1988528294","https://openalex.org/W1991688431","https://openalex.org/W1991796282","https://openalex.org/W1992805022","https://openalex.org/W1993638445","https://openalex.org/W1997145514","https://openalex.org/W2005097349","https://openalex.org/W2018085374","https://openalex.org/W2018976775","https://openalex.org/W2019902454","https://openalex.org/W2022378263","https://openalex.org/W2023985345","https://openalex.org/W2028789131","https://openalex.org/W2030886807","https://openalex.org/W2043807119","https://openalex.org/W2045720123","https://openalex.org/W2045946003","https://openalex.org/W2046050438","https://openalex.org/W2047826268","https://openalex.org/W2048718083","https://openalex.org/W2051008458","https://openalex.org/W2051098765","https://openalex.org/W2054674408","https://openalex.org/W2059738801","https://openalex.org/W2059776126","https://openalex.org/W2062851925","https://openalex.org/W2062959518","https://openalex.org/W2067119243","https://openalex.org/W2067410262","https://openalex.org/W2069648582","https://openalex.org/W2071113699","https://openalex.org/W2074243567","https://openalex.org/W2075692582","https://openalex.org/W2078448800","https://openalex.org/W2081013004","https://openalex.org/W2081384312","https://openalex.org/W2087512006","https://openalex.org/W2088186226","https://openalex.org/W2089552931","https://openalex.org/W2090977358","https://openalex.org/W2100946177","https://openalex.org/W2105588992","https://openalex.org/W2105611208","https://openalex.org/W2108413296","https://openalex.org/W2114723982","https://openalex.org/W2115456135","https://openalex.org/W2117919189","https://openalex.org/W2124057002","https://openalex.org/W2125922181","https://openalex.org/W2133895139","https://openalex.org/W2134261811","https://openalex.org/W2134902690","https://openalex.org/W2137270651","https://openalex.org/W2141900212","https://openalex.org/W2149132843","https://openalex.org/W2152574007","https://openalex.org/W2156488305","https://openalex.org/W2162201817","https://openalex.org/W2162553766","https://openalex.org/W2166580988","https://openalex.org/W2166655041","https://openalex.org/W2171509266","https://openalex.org/W2186821990","https://openalex.org/W2319873259","https://openalex.org/W2365074602","https://openalex.org/W2397635773","https://openalex.org/W2406583270","https://openalex.org/W2409022713","https://openalex.org/W2472776814"],"related_works":["https://openalex.org/W7217644171","https://openalex.org/W2084224801","https://openalex.org/W2069648582","https://openalex.org/W193297637","https://openalex.org/W1511797216","https://openalex.org/W3020757844","https://openalex.org/W3097088408","https://openalex.org/W2735949535","https://openalex.org/W108769585"],"abstract_inverted_index":{"Atopic":[0],"dermatitis":[1],"(AD)":[2],"is":[3,36,138,150],"a":[4,71,94,115,195],"chronic":[5],"or":[6],"chronically":[7],"relapsing":[8],"inflammatory":[9],"skin":[10,197],"condition":[11],"that":[12],"primarily":[13,139],"affects":[14],"children.":[15],"Topical":[16,136],"corticosteroids":[17,122],"have":[18,110,163],"been":[19,111,164],"the":[20,25,45,85,159],"mainstay":[21],"of":[22,44,49,75,88,158],"treatment":[23],"since":[24],"late":[26],"1950s.":[27],"While":[28],"providing":[29],"excellent":[30],"short-term":[31],"efficacy,":[32],"topical":[33,56,107,121,160,204],"corticosteroid":[34],"usage":[35],"limited":[37],"by":[38],"potential":[39],"adverse":[40],"effects,":[41],"including":[42],"impairment":[43],"function":[46],"and":[47,63,67,77,117,145,185,191,199],"viability":[48],"Langerhans":[50,81],"cells/dendritic":[51,82],"cells.":[52,83],"The":[53],"recently":[54],"introduced":[55],"calcineurin":[57,108,161],"inhibitors":[58,109,162],"pimecrolimus":[59,137],"cream":[60],"1%":[61],"(Elidel)":[62],"tacrolimus":[64,149],"ointment":[65],"0.03":[66],"0.1%":[68],"(Protopic)":[69],"exhibit":[70],"more":[72,154],"selective":[73,99],"mechanism":[74],"action":[76],"do":[78],"not":[79],"affect":[80],"For":[84],"immune":[86],"system":[87],"young":[89],"children":[90,142],"'learning'":[91],"to":[92,113,120,171],"mount":[93],"balanced":[95],"Th1/Th2":[96],"response,":[97],"this":[98],"effect":[100],"has":[101],"particular":[102],"benefits.":[103],"In":[104],"clinical":[105,192],"experience,":[106],"shown":[112],"be":[114],"safe":[116],"effective":[118],"alternative":[119],"in":[123,141,153,187],"almost":[124],"7":[125],"million":[126,129,133],"patients":[127],"(>5":[128],"on":[130,134],"pimecrolimus;":[131],">1.7":[132],"tacrolimus).":[135],"used":[140,151],"with":[143,166,178],"mild":[144],"moderate":[146],"AD,":[147],"whereas":[148],"preferentially":[152],"severe":[155],"cases.":[156],"None":[157],"associated":[165],"systemic":[167,176],"immunosuppression-related":[168],"malignancies":[169],"known":[170],"occur":[172],"following":[173],"long-term":[174],"sustained":[175],"immunosuppression":[177],"oral":[179],"immunosuppressants":[180],"(e.g.,":[181],"tacrolimus,":[182],"cyclosporine":[183],"A,":[184],"corticosteroids)":[186],"transplant":[188],"patients.":[189],"Preclinical":[190],"data":[193],"suggest":[194],"greater":[196],"selectivity":[198],"larger":[200],"safety":[201],"margin":[202],"for":[203],"pimecrolimus.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2028507366","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
